The Hain Celestial Group Inc is a health and wellness company... Show more
Hain Celestial's fiscal first quarter 2027 report lands at a pivotal moment for the health-and-wellness food maker. The company has spent the past year reshaping itself, selling its North American snacks business and pursuing a $323 million sale of its International segment to reduce a heavy debt load. Those moves have meaningfully improved margins, but they have also shrunk the top line and shifted investor attention from operating performance to the balance sheet. With the company's credit facility maturing in December and the International divestiture still unclosed, this quarter's results matter less for the headline loss and more for what they signal about Hain's ability to stabilize revenue, generate cash, and resolve its capital structure.
For the fiscal first quarter of 2027, ended September 30, 2026, Hain Celestial reported net sales of $260.3 million, a decline of 29.3% from the prior-year period and below the consensus estimate of roughly $283 million. The adjusted net loss was $0.07 per share, wider than the $0.04 per-share loss analysts had projected, though improved from a $0.08 adjusted loss a year earlier.
Organic net sales declined 6.7% year over year, reflecting a roughly 7-point decline in volume and mix. The profitability story, however, was stronger. Adjusted gross margin expanded about 320 basis points to 22.8%, helped by the exit of the lower-margin snacks business. North America posted a 33.5% adjusted gross margin and a 15.6% adjusted EBITDA margin. Selling, general and administrative expenses (SG&A) fell 6% to $62 million. Adjusted EBITDA was approximately $18 million, down from $19 million in the fourth quarter, while free cash flow was negative $23 million and net debt rose to about $523 million. The company provided no guidance and, for a second consecutive quarter, held no question-and-answer session on its call.
Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening, making it a practical resource for investors tracking events like Hain Celestial's earnings. Consider using the AI Screener to complement your own research and identify setups across the broader market.
Investor reaction to the report was negative, reflecting disappointment with the revenue and earnings shortfall and lingering anxiety over the company's financing. Shares fell roughly 7% to about $0.14 immediately after the results, underscoring how heavily the stock is now trading on balance-sheet risk rather than operational progress. The improving margin trajectory was largely overshadowed by two developments: the International sale's failure to close on schedule and the approaching December maturity of the company's credit facility. Management's shift in tone—from confidence about refinancing to "evaluating all available paths"—and the addition of a Nasdaq listing-risk disclosure in the company's risk factors further dampened sentiment. For now, the market appears to be pricing in continued distress rather than rewarding the company's margin gains.
The most important near-term catalyst is the resolution of Hain Celestial's capital structure. The $323 million International divestiture to AURELIUS remains contingent on a credit-agreement amendment, and the company's credit facility comes due in December. Whether Hain can refinance, extend, or otherwise address that maturity will likely determine the stock's direction more than any single operating metric in the months ahead.
On the operating side, investors should watch whether the North American margin improvements hold. Management has already actioned roughly $8 million of a planned $16 million SG&A savings program and removed the $25 million of stranded costs tied to the snacks sale ahead of schedule. Sustaining the 30%-plus pro forma gross margin target while stabilizing organic sales will be central to the turnaround narrative.
Top-line stability is another key factor. Organic revenue has now declined for multiple consecutive quarters, with baby & kids, beverages, and meal prep all under pressure. Watch for signs that volume and mix trends are stabilizing, as well as any commentary on the Greek Gods yogurt supply disruption and distribution losses that weighed on the quarter. Given the absence of formal guidance, investors will be closely parsing management's comments for visibility into fiscal 2027 revenue and cash-flow expectations.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of organic snack food and personal care products
Industry FoodMajorDiversified